Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Effect of Hypoxia on the Pathogenesis of Acinetobacter baumannii and Pseudomonas aeruginosa In Vitro and in Murine Experimental Models of Infection.

Gil-Marqués ML, Pachón-Ibáñez ME, Pachón J, Smani Y.

Infect Immun. 2018 Sep 21;86(10). pii: e00543-18. doi: 10.1128/IAI.00543-18. Print 2018 Oct.

2.

Assessment of antivirulence activity of several d-amino acids against Acinetobacter baumannii and Pseudomonas aeruginosa.

Rumbo C, Vallejo JA, Cabral MP, Martínez-Guitián M, Pérez A, Beceiro A, Bou G.

J Antimicrob Chemother. 2016 Dec;71(12):3473-3481. Epub 2016 Sep 7.

PMID:
27605598
3.

[Investigation of serum resistance for Pseudomonas aeruginosa and Acinetobacter baumannii strains].

Cevahir N, Kaleli I, Demir M, Yildirim U, Cevik E, Gürbüz M.

Mikrobiyol Bul. 2006 Jul;40(3):251-5. Turkish.

PMID:
17001855
4.
5.

A novel bacterial transport mechanism of Acinetobacter baumannii via activated human neutrophils through interleukin-8.

Kamoshida G, Tansho-Nagakawa S, Kikuchi-Ueda T, Nakano R, Hikosaka K, Nishida S, Ubagai T, Higashi S, Ono Y.

J Leukoc Biol. 2016 Dec;100(6):1405-1412. Epub 2016 Jun 30.

PMID:
27365529
6.

In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.

Cai Y, Wang R, Liang BB, An MM.

J Hosp Infect. 2009 Aug;72(4):368-70. doi: 10.1016/j.jhin.2009.03.013. Epub 2009 May 13. No abstract available.

PMID:
19443079
7.

Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection.

Qiu H, KuoLee R, Harris G, Van Rooijen N, Patel GB, Chen W.

PLoS One. 2012;7(6):e40019. doi: 10.1371/journal.pone.0040019. Epub 2012 Jun 29.

8.

Hypoxia modulates infection of epithelial cells by Pseudomonas aeruginosa.

Schaible B, McClean S, Selfridge A, Broquet A, Asehnoune K, Taylor CT, Schaffer K.

PLoS One. 2013;8(2):e56491. doi: 10.1371/journal.pone.0056491. Epub 2013 Feb 13.

9.

In Vitro Efficacy of Doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii by E-Test.

Gilani M, Munir T, Latif M, Rehman S, Ansari M, Hafeez A, Najeeb S, Saad N, Gilani M.

J Coll Physicians Surg Pak. 2015 Oct;25(10):726-9. doi: 10.2015/JCPSP.726729.

PMID:
26454387
10.

[Formation of bacterial biofilm on deep vein catheters in burn patients and its significance].

Xiang J, Sun Z, Song F, Han LZ, Huan JN.

Zhonghua Shao Shang Za Zhi. 2010 Apr;26(2):95-9. Chinese.

PMID:
20723406
11.

[Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].

Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.

Mikrobiyol Bul. 2008 Apr;42(2):321-9. Turkish.

PMID:
18697430
12.

Evaluation of the total MBL confirm kit (ROSCO) for detection of metallo-β-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii.

Hansen F, Hammerum AM, Skov R, Haldorsen B, Sundsfjord A, Samuelsen O.

Diagn Microbiol Infect Dis. 2014 Aug;79(4):486-8. doi: 10.1016/j.diagmicrobio.2013.12.001. Epub 2013 Dec 10.

PMID:
24857168
13.

Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America.

Labarca JA, Salles MJ, Seas C, Guzmán-Blanco M.

Crit Rev Microbiol. 2016;42(2):276-92. doi: 10.3109/1040841X.2014.940494. Epub 2014 Aug 27. Review.

PMID:
25159043
14.

Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

Dias VC, Resende JA, Bastos AN, De Andrade Bastos LQ, De Andrade Bastos VQ, Bastos RV, Diniz CG, Da Silva VL.

Microb Drug Resist. 2017 Oct;23(7):852-863. doi: 10.1089/mdr.2016.0219. Epub 2017 Feb 24.

PMID:
28437232
15.

[Carriage of class 1 and 2 integrons in Acinetobacter baumannii and Pseudomonas aeruginosa isolated from clinical specimens and a novel gene cassette array: blaOXA-11-cmlA7].

Mengeloğlu FZ, Copur Çiçek A, Koçoğlu E, Sandallı C, Budak EE, Ozgümüş OB.

Mikrobiyol Bul. 2014 Jan;48(1):48-58. Turkish.

16.

Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York City.

Abdallah M, Olafisoye O, Cortes C, Urban C, Charles C, Landman D, Quale J.

Am J Infect Control. 2015 Jun;43(6):650-2. doi: 10.1016/j.ajic.2015.02.018. Epub 2015 Mar 26.

PMID:
25818022
17.

Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.

Potron A, Poirel L, Nordmann P.

Int J Antimicrob Agents. 2015 Jun;45(6):568-85. doi: 10.1016/j.ijantimicag.2015.03.001. Epub 2015 Mar 24. Review.

PMID:
25857949
19.

Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii.

Smani Y, Dominguez-Herrera J, Pachón J.

J Infect Dis. 2013 Nov 15;208(10):1561-70. doi: 10.1093/infdis/jit386. Epub 2013 Aug 1.

PMID:
23908480
20.

Spread of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clones in patients with ventilator-associated pneumonia in an adult intensive care unit at a university hospital.

Royer S, Faria AL, Seki LM, Chagas TP, Campos PA, Batistão DW, Asensi MD, Gontijo Filho PP, Ribas RM.

Braz J Infect Dis. 2015 Jul-Aug;19(4):350-7. doi: 10.1016/j.bjid.2015.03.009. Epub 2015 May 19.

Supplemental Content

Support Center